Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThomaslloyd $ Regulatory News (TLEI)

  • This share is currently suspended. It was suspended at a price of 1.045
  • There is currently no data for TLEI

Kepler Trust Intelligence: New Research

19 Oct 2022 07:00

RNS Number : 3122D
ThomasLloyd Energy Impact - TLEI
19 October 2022
 

ThomasLloyd Energy Impact: New Research

19/10/2022

TLEI's impact and return objectives make it an interesting addition to the sector… The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADZMMGKRGGZZM
12
Date   Source Headline
30th Oct 20232:59 pmRNSChange of Name and Website Address
11th Oct 20237:00 amRNSCommencing RUMS Project & Investment Policy Update
28th Sep 20237:00 amRNSSelection of transitional investment manager
25th Sep 202311:25 amRNSResults of Second Requisitioned General Meeting
15th Sep 20237:00 amRNSUpdate on Investment Management Arrangements
1st Sep 20237:00 amRNSNotice of a Second Requisitioned General Meeting
25th Aug 20234:37 pmRNSExchange Rate for the Interim Dividend
24th Aug 202312:23 pmRNSResult of Requisitioned GM and Adjourned AGM
17th Aug 20233:05 pmRNSResponse to announcement by ThomasLloyd Group
17th Aug 20237:00 amRNSResponse to announcement by ThomasLloyd Group
15th Aug 20237:00 amRNSUpdate re material new information
11th Aug 20231:48 pmRNSRequisition of a General Meeting
10th Aug 20237:00 amRNSDividend Declaration
31st Jul 20237:00 amRNSNotices of Requisitioned GM and Adjourned AGM
12th Jul 20234:49 pmRNSRequisition of a General Meeting
12th Jul 20237:00 amRNSPortfolio valuation update
7th Jul 20237:00 amRNSExchange Rate for the Interim Dividend
30th Jun 202312:48 pmRNSResult of AGM
29th Jun 20231:40 pmRNSChange of AGM location and time
6th Jun 20237:00 amRNSNotice of AGM and Dividend Declaration
11th May 202311:51 amRNSExchange Rate For The Interim Dividend
25th Apr 20237:50 amRNSCorrecting RNS re Temporary Share Suspension
24th Apr 20238:17 amRNSTemporary Share Suspension
13th Apr 20235:25 pmRNSDividend Declaration
7th Mar 20235:20 pmRNSHolding(s) in Company
20th Jan 20234:57 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSCompletion of Final SolarArise Acquisition
13th Dec 20225:12 pmRNSHolding(s) in Company
9th Dec 20227:00 amRNSInvestment Manager - Senior Appointments
30th Nov 20224:56 pmRNSTotal Voting Rights
28th Nov 20224:51 pmRNSHolding(s) in Company
24th Nov 20224:57 pmRNSHolding(s) in Company
23rd Nov 20221:44 pmRNSHolding(s) in Company
23rd Nov 20227:00 amRNSExchange Rate for the Interim Dividend
18th Nov 20224:43 pmRNSHolding(s) in Company
18th Nov 20224:41 pmRNSHolding(s) in Company
18th Nov 20224:40 pmRNSHolding(s) in Company
16th Nov 20227:00 amRNSResults of Subsequent Placing
15th Nov 20222:24 pmRNSSterling Equivalent Subsequent Placing Price
8th Nov 20227:00 amRNSProposed Subsequent Placing and Pipeline Update
3rd Nov 20227:00 amRNSNet Asset Value, Dividend and Operational Update
2nd Nov 20227:00 amRNSEntry into Vietnam/ IPO Proceeds Deployment Update
19th Oct 20227:00 amRNSKepler Trust Intelligence: New Research
23rd Sep 20227:00 amRNSAppointment of Joint Corporate Broker
23rd Sep 20227:00 amRNSAppointment of Joint Corporate Broker
22nd Sep 202211:32 amRNSExchange rate for the interim dividend
14th Sep 20225:22 pmRNSHolding(s) in Company
8th Sep 202212:43 pmRNSHolding(s) in Company
7th Sep 20227:01 amRNSInterim results for the period ended 30 June 2022
7th Sep 20227:00 amRNSDividend Declaration
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.